Trial
NCT04035109
Anakinra as a Rescue Treatment for Allergic Inflammation
Phase IWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
University of North Carolina, Chapel Hill
Collaborators
National Heart, Lung, and Blood Institute (NHLBI)
Condition
Asthma, Allergic
Intervention
Anakinra
Why stopped
Study stopped due to COVID-19 pandemic.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2022-06-08